Previous studies showed that miR-326 and miR-339-3p are significantly decreased in AML-derived samples [35,38] and that miR-326 may inhibit proliferation but promote apoptosis and phorbol myristate acetate (PMA)-induced differentiation through downregulating c-Myc in AML [39]. The gene discussed is MYC; the disease is acute myeloid leukemia.